Differential infection of murine and human dendritic cell subsets by oncolytic vesicular stomatitis virus variants

Differential infection of murine and human dendritic cell subsets by oncolytic vesicular stomatitis virus variants

Oncolytic viruses (OVs) can eradicate tumor cells and elicit antitumor immunity. VSV-GP, a chimeric vesicular stomatitis virus (VSV) with the glycoprotein (GP) of the lymphocytic choriomeningitis virus, is a promising new OV candidate. However, the interaction of VSV-GP with host immune cells is not...

Full description

Bibliographic Details
Main Authors: Lisa Pipperger, Lydia Riepler, Janine Kimpel, Anita Siller, Patrizia Stoitzner, Zoltán Bánki, Dorothee von Laer
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:OncoImmunology
Subjects:
oncolytic viruses
dendritic cells
vesicular stomatitis virus
infection
Online Access:http://dx.doi.org/10.1080/2162402X.2021.1959140

Similar Items

Similar Items